RecruitingNCT05468008
Endoscopic Submucosal Dissection (ESD)
Prospective Evaluation of the Clinical Utility of Endoscopic Submucosal Dissection (ESD) in Western Population
Sponsor
AdventHealth
Enrollment
1,000 participants
Start Date
Feb 4, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
This registry is to evaluate the procedural and clinical outcomes in patients undergoing endoscopic submucosal dissection. All patients will receive standard of medical care and no experimental interventions will be performed.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Age 18 years or older
- Scheduled to undergo ESD
Exclusion Criteria2
- Any contraindication to performing endoscopy
- Participation in another research protocol that could interfere or influence the outcomes measures of the present study.
Interventions
PROCEDUREEndoscopic Submucosal Dissection
Endoscopic submucosal dissection (ESD) is an outpatient procedure to remove deep tumors from the gastrointestinal (GI) tract
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05468008
Related Trials
Obeticholic Acid for Prevention in Barrett's Esophagus
NCT049390518 locations
Non-Endoscopic Detection of Barrett's Esophagus Using Methylation Biomarkers on EndoSign® Cell Collection Device Samples
NCT068039271 location
Impact of RFA on Esophageal Distensibility and Mucosal Impedance
NCT071265351 location
Molecular Assessment for Gastro-Esophageal Cancer
NCT063460541 location
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
NCT039619459 locations